Regal Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $948K | Hold |
2,906
| – | – | 0.07% | 246 |
|
|
2025
Q1 | $785K | Sell |
2,906
-252
| -8% | -$68K | 0.06% | 250 |
|
|
2024
Q4 | $743K | Sell |
3,158
-19
| -0.6% | -$4.47K | 0.06% | 269 |
|
|
2024
Q3 | $874K | Sell |
3,177
-171
| -5% | -$47K | 0.06% | 265 |
|
|
2024
Q2 | $814K | Buy |
3,348
+132
| +4% | +$32.1K | 0.05% | 280 |
|
|
2024
Q1 | $481K | Buy |
3,216
+251
| +8% | +$37.5K | 0.03% | 371 |
|
|
2023
Q4 | $568K | Buy |
2,965
+162
| +6% | +$31K | 0.04% | 303 |
|
|
2023
Q3 | $496K | Buy |
2,803
+8
| +0.3% | +$1.42K | 0.04% | 296 |
|
|
2023
Q2 | $531K | Buy |
2,795
+853
| +44% | +$162K | 0.04% | 284 |
|
|
2023
Q1 | $389K | Buy |
+1,942
| New | +$389K | 0.03% | 335 |
|